Papers

1

Total Citations

4

H-Index

1

About

Dr. Long-Chun Chen is a leading expert in radiation oncology and medical physics, with a focused research portfolio in stereotactic radiosurgery and secondary cancer risk assessment. Her seminal work, "Plan Quality and Secondary Cancer Risk Assessment in Patients with Benign Intracranial Lesions after Radiosurgery using the CyberKnife M6 Robotic Radiosurgery System" (2019), has garnered 4 citations and represents a critical contribution to the field. In this study, Dr. Chen systematically compared treatment planning quality and modality—specifically, multileaf collimator (MLC)-based plans versus IRIS-based plans—to evaluate dose–response relationships for secondary malignancy risks. Her findings provide actionable insights for optimizing radiosurgery delivery in benign intracranial lesions, balancing tumor control with long-term patient safety. Dr. Chen’s work is instrumental in advancing precision radiotherapy, particularly in minimizing late radiation effects. Her research bridges the gap between cutting-edge technology and clinical outcomes, making her a respected voice in radiation oncology. For students and researchers, her studies underscore the importance of integrating dosimetric analysis with patient-centered risk assessment, offering a model for evidence-based practice in modern radiosurgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Plan Quality and Secondary Cancer Risk Assessment in Patients with Benign Intracranial Lesions after Radiosurgery using the CyberKnife M6 Robotic Radiosurgery System
4 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: National Kaohsiung University of Science and Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago